Calyx Chemicals and Pharmaceuticals today said it has approached market regulator Sebi for permission to tap the capital market with an initial public offer.
The company, a manufacturer of active pharmaceutical ingredients and intermediates, said it "has filed the Draft Red Herring Prospectus (DRHP) with Securities and Exchange Board of India (Sebi) for an Initial Public Offering".
The issue will be of 68.3 lakh equity shares of face value of Rs 10 each for cash at a price to be determined through the 100% book-building process. The issue also includes an employee reservation portion of 50,000 equity shares.
However, the company has not disclosed about the utilisation of fund from the proceeds.
PL Capital Markets Pvt Ltd, Yes Bank and Punjab National Bank are the book running lead managers to the issue.
The company's standalone net sales grew to Rs 321.80 crore in 2009-10 from Rs 235.01 crore in the previous year, while profit after tax rose to Rs 21.89 crore in 2009-10 from Rs 15.48 crore in 2008-09.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app